Department of Nuclear Medicine and Tracer Kinetics Osaka University Graduate School of Medicine
HOME
HOMEPublications2014-2017
About Our Department
Research Contents
Osaka University, Graduate School of Medicine / Faculty of Medicine
Osaka University
Publications
1994 1995 1996 1997 1998 1999 2000 2001 2002
  2003 2004 2005 2006 2007 2008 2009     2011-2013
2014-2017                                
2017
   
 
  1. Amer H, Niaz K, Hatazawa J, Gasmelseed A, Samiri HA, Al Othman M, Hammad MA. Future cardiac events in patients with ischemic ECG changes during adenosine infusion as a myocardial stress agent and normal cardiac scan. Nucl Med Commun. 2017 Sep 11.
  2. Wu R, Watanabe Y, Arisawa A, Takahashi H, Tanaka H, Fujimoto Y, Watabe T, Isohashi K, Hatazawa J, Tomiyama N. Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading. Jpn J Radiol. 2017 Sep 6.
  3. Morita T, Tatsumi M, Ishibashi M, Isohashi K, Kato H, Honda O, Shimosegawa E, Tomiyama N, Hatazawa J. Assessment of Mediastinal Tumors Using SUV(max) and Volumetric Parameters on FDG-PET/CT. Asia Ocean J Nucl Med Biol. 2017 Winter;5(1):22-29.
  4. Mochida I, Shimosegawa E, Kanai Y, Naka S, Matsunaga K, Isohashi K, Horitsugi G, Watabe T, Kato H, Hatazawa J. Whole-Body Distribution of Donepezil as an Acetylcholinesterase Inhibitor after Oral Administration in Normal Human Subjects: A (11)C-donepezil PET Study. Asia Ocean J Nucl Med Biol. 2017 Winter;5(1):3-9.
  5. Miyabe J, Hanamoto A, Tatsumi M, Hamasaki T, Takenaka Y, Nakahara S, Kishikawa T, Suzuki M, Takemoto N, Michiba T, Yoshioka Y, Isohashi F, Konishi K, Ogawa K, Hatazawa J, Inohara H. Metabolic tumor volume of primary tumor predicts survival better than T classification in the larynx preservation approach. Cancer Sci. 2017 Aug 8.
  6. Sakane M, Tatsumi M, Hori M, Onishi H, Tsuboyama T, Nakamoto A, Ota T, Eguchi H, Wakasa K, Hatazawa J, Tomiyama N. Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography can predict histopathologic treatment response after neoadjuvant chemoradiotherapy in pancreatic adenocarcinoma. Eur J Radiol. 2017 Jun 23. pii:S0720-048X(17)30200-0.
  7. Makino T, Yamasaki M, Tanaka K, Tatsumi M, Takiguchi S, Hatazawa J, Mori M, Doki Y. Importance of positron emission tomography for assessing the response of primary and metastatic lesions to induction treatments in T4 esophageal cancer. Surgery. 2017 Oct;162(4):836-845. doi: 10.1016/j.surg.2017.06.007.
  8. Kanoto M, Kirii K, Hiraka T, Toyoguchi Y, Sugai Y, Matsuda K, Sakurada K, Sonoda Y, Hatazawa J, Hosoya T. Correlation between hypoxic area in primary brain tumors and WHO grade: differentiation from malignancy using 18F-fluoromisonidazole positron emission tomography. Acta Radiol. 2017 Jan 1:284185117711474.
  9. Kishimoto A, Kataoka J, Taya T, Tagawa L, Mochizuki S, Ohsuka S, Nagao Y, Kurita K, Yamaguchi M, Kawachi N, Matsunaga K, Ikeda H, Shimosegawa E, Hatazawa J. First demonstration of multi-color 3-D in vivo imaging using ultra-compact Compton camera. Sci Rep. 2017 May 18;7(1):2110.
  10. Watabe T, Hanaoka K, Naka S, Kanai Y, Ikeda H, Aoki M, Shimosegawa E, Kirihata M, Hatazawa J. Practical calculation method to estimate the absolute boron concentration in tissues using (18)F-FBPA PET. Ann Nucl Med. 2017 Jul;31(6):481-485.
  11. Watabe T, Kanai Y, Ikeda H, Horitsugi G, Matsunaga K, Kato H, Isohashi K, Abe K, Shimosegawa E, Hatazawa J. Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia: (18)F-fluoromisonidazole and (15)O-labelled gases inhalation PET. EJNMMI Res. 2017 Dec;7(1):16.
  12. Watabe T, Ikeda H, Nagamori S, Wiriyasermkul P, Tanaka Y, Naka S, Kanai Y, Hagiwara K, Aoki M, Shimosegawa E, Kanai Y, Hatazawa J. (18)F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with (18)F-FDG and (11)C-Methionine PET. Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):321-331.
  13. Momosaki S, Ito M, Yamato H, Iimori H, Sumiyoshi H, Morimoto K, Imamoto N, Watabe T, Shimosegawa E, Hatazawa J, Abe K. Longitudinal imaging of the availability of dopamine transporter and D2 receptor in rat striatum following mild ischemia. J Cereb Blood Flow Metab. 2017 Feb;37(2):605-613.
2015
  1. Kashiyama N, Miyagawa S, Fukushima S, Kawamura T, Kawamura A, Yoshida S, Harada A, Watabe T, Kanai Y, Toda K, Hatazawa J, Sawa Y. Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice. PLoS One. 2016 Dec 8;11(12):e0165748.
  2. Kinoshita M, Arita H, Okita Y, Kagawa N, Kishima H, Hashimoto N, Tanaka H, Watanabe Y, Shimosegawa E, Hatazawa J, Fujimoto Y, Yoshimine T. Comparison of diffusion tensor imaging and (11)C-methionine positron emission tomography for reliable prediction of tumor cell density in gliomas. J Neurosurg. 2016 Nov;125(5):1136-1142.
  3. Yamamoto S, Watabe T, Ikeda H, Kanai Y, Ichikawa K, Nakao M, Kato K, Hatazawa J. Development of a PET/OMRI combined system for simultaneous imaging of positron and free radical probes for small animals. Med Phys. 2016 Oct;43(10):5676.
  4. Isohashi K, Shimosegawa E, Naka S, Kanai Y, Horitsugi G, Mochida I, Matsunaga K, Watabe T, Kato H, Tatsumi M, Hatazawa J. Comparison of the image-derived radioactivity and blood-sample radioactivity for estimating the clinical indicators of the efficacy of boron neutron capture therapy (BNCT): 4-borono-2-18F-fluoro-phenylalanine (FBPA) PET study. EJNMMI Res. 2016 Dec;6(1):75.
  5. Shimosegawa E, Isohashi K, Naka S, Horitsugi G, Hatazawa J. Assessment of (10)B concentration in boron neutron capture therapy: potential of image-guided therapy using (18)FBPA PET. Ann Nucl Med. 2016 Dec;30(10):749-755.
  6. Watanabe M, Honda C; Osaka Twin Research Group, Iwatani Y, Yorifuji S, Iso H, Kamide K, Hatazawa J, Kihara S, Sakai N, Watanabe H, Makimoto K, Watanabe M, Honda C, Iwatani Y. Within-pair differences of DNA methylation levels between monozygotic twins are different between male and female pairs. BMC Med Genomics. 2016 Aug 26;9(1):55.
  7. Kato H, Shimosegawa E, Fujino K, Hatazawa J. CT-Based Attenuation Correction in Brain SPECT/CT Can Improve the Lesion Detectability of Voxel-Based Statistical Analyses. PLoS One. 2016 Jul 21;11(7):e0159505.
  8. Kawamura A, Miyagawa S, Fukushima S, Kawamura T, Kashiyama N, Ito E, Watabe T, Masuda S, Toda K, Hatazawa J, Morii E, Sawa Y. Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice. Sci Rep. 2016 Jan 14;6:19464.
  9. Watanabe S, Kato H, Shimosegawa E, Hatazawa J. Genetic and Environmental Influences on Regional Brain Uptake of 18F-FDG: A PET Study on Monozygotic and Dizygotic Twins. J Nucl Med. 2016 Mar;57(3):392-7.
  10. Araki T, Hirata M, Yanagisawa T, Sugata H, Onishi M, Watanabe Y, Ogata S, Honda C, Hayakawa K, Yorifuji S; Osaka Twin Research Group.. Language-related cerebral oscillatory changes are influenced equally by genetic and environmental factors. Neuroimage. 2016 Nov 15;142:241-247. doi: 10.1016/j.neuroimage.2016.05.066. Epub 2016 May 27.
  11. Takano K, Kinoshita M, Arita H, Okita Y, Chiba Y, Kagawa N, Fujimoto Y, Kishima H, Kanemura Y, Nonaka M, Nakajima S, Shimosegawa E, Hatazawa J, Hashimoto N, Yoshimine T. Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas. AJNR Am J Neuroradiol. 2016 Jan;37(1):44-50.
  12. Tanaka H, Ogata S, Omura K, Honda C; Osaka Twin Research Group., Kamide K, Hayakawa K. Association between subjective memory complaints and depressive symptoms after adjustment for genetic and family environmental factors in a Japanese twin study. Environ Health Prev Med. 2016 Mar;21(2):92-9.
  13. Maya Y, Okumura Y, Kobayashi R, Onishi T, Shoyama Y, Barret O, Alagille D, Jennings D, Marek K, Seibyl J, Tamagnan G, Tanaka A, Shirakami Y. Preclinical properties and human in vivo assessment of 123I-ABC577 as a novel SPECT agent for imaging amyloid-β. Brain. 2016 Jan;139(Pt 1):193-203.
  14. Miyata H, Yamasaki M, Makino T, Tatsumi M, Miyazaki Y, Takahashi T, Kurokawa Y, Takiguchi S, Mori M, Doki Y. Impact of number of [(18)F]fluorodeoxyglucose-PET-positive lymph nodes on survival of patients receiving?neoadjuvant chemotherapy and surgery for oesophageal cancer. Br J Surg. 2016 Jan;103(1):97-104.
  15. Tanaka Y, Ueda Y, Egawa-Takata T, Matsuzaki S, Kobayashi E, Yoshino K, Enomoto T, Tatsumi M, Kimura T. Early metabolic change in (18)F-FDG-PET by measuring the single largest lesion predicts chemotherapeutic effects and patients' survival: PEACH study. Cancer Chemother Pharmacol. 2016 Jan;77(1):121-6.
  16. Fujimori T, Watabe T, Iwamoto Y, Hamada S, Iwasaki M, Oda T. Prevalence, Concomitance, and Distribution of Ossification of the Spinal Ligaments: Results of Whole Spine CT Scans in 1500 Japanese Patients. Spine (Phila Pa 1976). 2016 Nov 1;41(21):1668-1676.
  17. Goto Y, Kumura E, Watabe T, Nakamura H, Nishino A, Koyama T, Taniwaki K, Yuguchi T, Yoshimine T. Prediction of Malignant Middle Cerebral Artery Infarction in Elderly Patients. J Stroke Cerebrovasc Dis. 2016 Jun;25(6):1389-95.
2015
  1. Isohashi K, Tatsumi M, Kato H, Fukushima K, Maeda T, Watabe T, Shimosegawa E, Kanakura Y, Hatazawa J. Prognostic Value of FDG-PET, Based on the Revised Response Criteria, in Patients with Malignant Lymphoma: A Comparison with CT/MRI Evaluations, Based on the International Working Group/Cotswolds Meeting Criteria. Asia Ocean J Nucl Med Biol. 2015 Summer;3(2):91-8.
  2. Watabe T, Hatazawa J. (18)F-FBPA as a tumor specific tracer of L-type amino acid transporter 1 (LAT1): PET evaluation in tumor and inflammation compared to (18)F-FDG and (11)C-methionine. Hell J Nucl Med. 2015 Sep-Dec;18 Suppl 1:149.
  3. Yamamoto S, Okumura S, Watabe T, Ikeda H, Kanai Y, Toshito T, Komori M, Ogata Y, Kato K, Hatazawa J. Development of a prototype Open-close positron emission tomography system. Rev Sci Instrum. 2015 Aug;86(8):084301.
  4. Nakatani K, Watabe T, Masuda D, Imaizumi M, Shimosegawa E, Kobayashi T, Sairyo M, Zhu Y, Okada T, Kawase R, Nakaoka H, Naito A, Ohama T, Koseki M, Oka T, Akazawa H, Nishida M, Komuro I, Sakata Y, Hatazawa J, Yamashita S. Myocardial energy provision is preserved by increased utilization of glucose and ketone bodies in CD36 knockout mice. Metabolism. 2015 Sep;64(9):1165-74.
  5. Hatazawa J. (18)F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma. Eur J Nucl Med Mol Imaging. 2015 May;42(6):885.
  6. Onishi H, Hatazawa J, Nakagawara J, Ito K, Ha-Kawa SK, Masuda Y, Sugibayashi K, Takahashi M, Kikuchi K, Katsuta N. Impact of injected dose and acquisition time on a normal database by use of 3D-SSP in SPECT images: quantitative simulation studies. Radiol Phys Technol. 2015 Jul;8(2):224-31.
  7. Kainuma S, Miyagawa S, Fukushima S, Pearson J, Chen YC, Saito A, Harada A, Shiozaki M, Iseoka H, Watabe T, Watabe H, Horitsugi G, Ishibashi M, Ikeda H, Tsuchimochi H, Sonobe T, Fujii Y, Naito H, Umetani K, Shimizu T, Okano T, Kobayashi E, Daimon T, Ueno T, Kuratani T, Toda K, Takakura N, Hatazawa J, Shirai M, Sawa Y. Cell-sheet Therapy with Omentopexy Promotes Arteriogenesis and Improves Coronary Circulation Physiology in Failing Heart. Mol Ther. 2015 Feb;23(2):374-86.
2014
  1. Takata K, Kato H, Shimosegawa E, Okuno T, Koda T, Sugimoto T, Mochizuki H, Hatazawa J, Nakatsuji Y. 11C-Acetate PET Imaging in Patients with Multiple Sclerosis. PLoS One. 2014 Nov 4;9(11):e111598.
  2. Sakane M, Tatsumi M, Kim T, Hori M, Onishi H, Nakamoto A, Eguchi H, Nagano H, Wakasa K, Hatazawa J, Tomiyama N. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma. Acta Radiol. 2014 Sep 29.
  3. Watabe T, Naka S, Ikeda H, Horitsugi G, Kanai Y, Isohashi K, Ishibashi M, Kato H, Shimosegawa E, Watabe H, Hatazawa J. Distribution of intravenously administered acetylcholinesterase inhibitor and acetylcholinesterase activity in the adrenal gland: 11C-donepezil PET study in the normal rat. PLoS One. 2014 Sep 16;9(9):e107427.
  4. Yamamoto S, Hamamura F, Watabe T, Ikeda H, Kanai Y, Watabe H, Kato K, Ogata Y, Hatazawa J. Development of a PET/Cerenkov-light hybrid imaging system. Med Phys. 2014 Sep;41(9):092504.
  5. Yamamoto S, Watabe T, Ikeda H, Kanai Y, Watabe H, Ogata Y, Kato K, Hatazawa J. Ultrahigh-resolution Cerenkov-light imaging system for positron radionuclides: potential applications and limitations. Ann Nucl Med. 2014 Aug 8. (in press)
  6. Watabe T, Shimosegawa E, Kato H, Isohashi K, Ishibashi M, Tatsumi M, Kitagawa K, Fujinaka T, Yoshimine T, Hatazawa J. Paradoxical reduction of cerebral blood flow after acetazolamide loading: a hemodynamic and metabolic study with (15)O PET. Neurosci Bull. 2014 Oct;30(5):845-56.
  7. Watabe T, Shimosegawa E, Kato H, Isohashi K, Ishibashi M, Hatazawa J. CBF/CBV maps in normal volunteers studied with (15)O PET: a possible index of cerebral perfusion pressure. Neurosci Bull. 2014 Oct;30(5):857-62.
  8. Hanamoto A, Tatsumi M, Takenaka Y, Hamasaki T, Yasui T, Nakahara S, Yamamoto Y, Seo Y, Isohashi F, Ogawa K, Hatazawa J, Inohara H. Volumetric PET/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapy. Cancer Med. 2014 Oct;3(5):1368-76.
  9. Yamauchi M, Imabayashi E, Matsuda H, Nakagawara J, Takahashi M, Shimosegawa E, Hatazawa J, Suzuki M, Iwanaga H, Fukuda K, Iihara K, Iida H. Quantitative assessment of rest and acetazolamide CBF using quantitative SPECT reconstruction and sequential administration of (123)I-iodoamphetamine: comparison among data acquired at three institutions. Ann Nucl Med. 2014 Jul 8. (in press)
  10. Hosono M, Saga T, Ito K, Kumita S, Sasaki M, Senda M, Hatazawa J, Watanabe H, Ito H, Kanaya S, Kimura Y, Saji H, Jinnouchi S, Fukukita H, Murakami K, Kinuya S, Yamazaki J, Uchiyama M, Uno K, Kato K, Kawano T, Kubota K, Togawa T, Honda N, Maruno H, Yoshimura M, Kawamoto M, Ozawa Y. Clinical practice guideline for dedicated breast PET. Ann Nucl Med. 2014 Jul;28(6):597-602.
  11. Tamura M, Matsui H, Hirohara S, Kakiuchi K, Tanihara M, Takahashi N, Nakai K, Kanai Y, Watabe H, Hatazawa J. Selective accumulation of [?²Zn]-labeled glycoconjugated porphyrins as multi-functional positron emission tomography tracers in cancer cells. Bioorg Med Chem. 2014 Apr 15;22(8):2563-70.
  12. Tsuboyama T, Tatsumi M, Onishi H, Nakamoto A, Kim T, Hori M, Sakane M, Hori Y, Morii E, Hatazawa J, Tomiyama N. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses. Invest Radiol. 2014 Aug;49(8):524-31.
  13. Yamamoto S, Watabe H, Kanai Y, Kato K, Hatazawa J. Development of a high-resolution YSO gamma camera system that employs 0.8-mm pixels. Ann Nucl Med. 2014 Apr;28(3):232-40.
  14. Miyata H, Yamasaki M, Takahashi T, Murakami K, Tanaka K, Yukinori K, Nakajima K, Takiguchi S, Morii E, Hatazawa J, Mori M, Doki Y. Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET). Ann Surg Oncol. 2014 Feb;21(2):575-82.
1994 1995 1996 1997 1998 1999 2000 2001 2002
  2003 2004 2005 2006 2007 2008 2009   2011-2013  
2014-2017                              
Copyright (C) Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, All Rights Reserved.